Table 4.
Number and percentage of ciprofloxacin or cefotaxime-resistant E. coli isolates resistant to the antibiotics tested in the EUVSEC panel.
| Antibiotic | Number of Ciprofloxacin-Resistant E. coli Isolates Resistant to the Antibiotic Listed (%) | Number of Cefotaxime-resistant E. coli Isolates Resistant to the Antibiotic Listed (%) |
|---|---|---|
| Ampicillin | 41 (78.8%) | 22 (100.0%) |
| Azithromycin | 4 (7.7%) | 4 (18.2%) |
| Cefotaxime | 3 (5.8%) | 22 (100.0%) |
| Ceftazidime | 1 (1.9%) | 21 (95.5%) |
| Chloramphenicol | 22 (42.3%) | 3 (13.6%) |
| Ciprofloxacin | 52 (100.0%) | 7 (31.8%) |
| Colistin | 0 | 1 (4.5%) |
| Gentamicin | 3 (5.8%) | 0 |
| Meropenem | 0 | 0 |
| Nalidixic Acid | 48 (92.3%) | 4 (18.2%) |
| Sulfamethoxazole | 47 (90.4%) | 4 (18.2%) |
| Tetracycline | 31 (59.6%) | 13 (59.1%) |
| Tigecycline | 0 | 0 |
| Trimethoprim | 38 (73.1%) | 16 (72.7%) |